ES2159347T3 - Naftil-acetamidas como inhibidores de spla2. - Google Patents

Naftil-acetamidas como inhibidores de spla2.

Info

Publication number
ES2159347T3
ES2159347T3 ES96308915T ES96308915T ES2159347T3 ES 2159347 T3 ES2159347 T3 ES 2159347T3 ES 96308915 T ES96308915 T ES 96308915T ES 96308915 T ES96308915 T ES 96308915T ES 2159347 T3 ES2159347 T3 ES 2159347T3
Authority
ES
Spain
Prior art keywords
acetamids
naftil
spla2 inhibitors
compounds
spla2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96308915T
Other languages
English (en)
Inventor
Theodore Goodson Jr
Richard Waltz Harper
David Kent Herron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9602267.8A external-priority patent/GB9602267D0/en
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2159347T3 publication Critical patent/ES2159347T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/11—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

SE DESCRIBE UNA CLASE DE NUEVOS COMPUESTOS DE ACETAMIDA DE NAFTILO DE FORMULA (I) JUNTO CON EL USO DE DICHOS COMPUESTOS PARA INHIBIR LA LIBERACION MEDIADA POR SPLA{SUB,2} DE ACIDOS GRASOS PARA TRATAMIENTO DE CONDICIONES COMO CHOQUE SEPTICO.
ES96308915T 1995-12-13 1996-12-09 Naftil-acetamidas como inhibidores de spla2. Expired - Lifetime ES2159347T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US855895P 1995-12-13 1995-12-13
GBGB9602267.8A GB9602267D0 (en) 1996-02-05 1996-02-05 Naphthyl acetamides as sPLA2 inhibitors

Publications (1)

Publication Number Publication Date
ES2159347T3 true ES2159347T3 (es) 2001-10-01

Family

ID=26308607

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96308915T Expired - Lifetime ES2159347T3 (es) 1995-12-13 1996-12-09 Naftil-acetamidas como inhibidores de spla2.

Country Status (17)

Country Link
US (1) US6160175A (es)
EP (1) EP0779271B1 (es)
JP (1) JP2000501739A (es)
KR (1) KR19990072110A (es)
AT (1) ATE203744T1 (es)
AU (1) AU1289797A (es)
BR (1) BR9612347A (es)
CA (1) CA2240395A1 (es)
DE (1) DE69614232T2 (es)
DK (1) DK0779271T3 (es)
ES (1) ES2159347T3 (es)
GR (1) GR3036988T3 (es)
HU (1) HUP9901984A3 (es)
IL (1) IL124866A (es)
MX (1) MX9804751A (es)
PT (1) PT779271E (es)
WO (1) WO1997021664A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177440B1 (en) 1996-10-30 2001-01-23 Eli Lilly And Company Substituted tricyclics
US6713645B1 (en) * 1996-10-30 2004-03-30 Eli Lilly And Company Substituted tricyclics
US5916922A (en) * 1996-12-03 1999-06-29 Eli Lilly And Company Phenyl glyoxamides as SPLA2 inhibitors
US6353128B1 (en) * 1996-12-03 2002-03-05 Eli Lilly And Company Phenyl acetamides as sPLA2 inhibitors
CA2326522A1 (en) 1998-03-31 1999-10-14 Shionogi & Co., Ltd. Pyrrolo[1,2-a]pyrazine spla2 inhibitor
ID23219A (id) * 1998-04-17 2000-03-30 Lilly Co Eli Trisiklik tersubstitusi
DZ2769A1 (fr) * 1998-04-17 2003-12-01 Lilly Co Eli Composés tricycliques substitués.
CA2332528A1 (en) 1998-05-21 1999-11-25 Shionogi & Co., Ltd. Pyrrolo[1,2-b]pyridazine spla2 inhibitory
WO2000021563A1 (fr) * 1998-10-14 2000-04-20 Shionogi & Co., Ltd. Moyens de traitement et de prevention contre les troubles ischemiques dus a la repercussion
JP4636521B2 (ja) 1999-07-19 2011-02-23 塩野義製薬株式会社 ｓＰＬＡ２阻害作用を有する三環系化合物
JP4636522B2 (ja) 1999-08-02 2011-02-23 塩野義製薬株式会社 ｓＰＬＡ２阻害作用を有する三環式化合物
US6787545B1 (en) 1999-08-23 2004-09-07 Shiongi & Co., Ltd. Pyrrolotriazine derivatives having spla2-inhibitory activities
WO2001036420A1 (fr) 1999-11-15 2001-05-25 Shionogi & Co., Ltd. Derives d'aza-indolizine tricyclique ayant un effet inhibiteur sur spla¿2?
AU2001267823A1 (en) 2000-06-29 2002-01-08 Shionogi And Co., Ltd. Compounds exhibiting x-type spla2 inhibiting effect
WO2002000256A1 (en) 2000-06-29 2002-01-03 Shionogi & Co., Ltd. Remedies for cirrhosis
TWI314457B (es) 2001-03-19 2009-09-11 Shionogi & Co
US20060064279A1 (en) * 2004-09-17 2006-03-23 Eric Baum Algorithm for retrieval of ocean surface temperature, wind speed and wind direction from remote microwave radiometric measurements

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3820463A1 (de) * 1988-06-16 1989-12-21 Basf Ag Strahlungsempfindliche, ethylenisch ungesaettigte, copolymerisierbare verbindungen und verfahren zu deren herstellung
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
HUP9901984A3 (en) 2001-01-29
EP0779271A1 (en) 1997-06-18
ATE203744T1 (de) 2001-08-15
IL124866A0 (en) 1999-01-26
US6160175A (en) 2000-12-12
EP0779271B1 (en) 2001-08-01
HUP9901984A2 (hu) 1999-10-28
JP2000501739A (ja) 2000-02-15
MX9804751A (es) 1998-10-31
PT779271E (pt) 2001-11-30
CA2240395A1 (en) 1997-06-19
DE69614232D1 (de) 2001-09-06
AU1289797A (en) 1997-07-03
IL124866A (en) 2002-08-14
KR19990072110A (ko) 1999-09-27
DK0779271T3 (da) 2001-10-08
WO1997021664A1 (en) 1997-06-19
GR3036988T3 (en) 2002-01-31
DE69614232T2 (de) 2002-01-10
BR9612347A (pt) 1999-07-13

Similar Documents

Publication Publication Date Title
ES2179088T3 (es) Inhibidores de flsa2 1h-indol-3-glioxilamida.
ES2159347T3 (es) Naftil-acetamidas como inhibidores de spla2.
EA199900301A2 (ru) Замещенные трициклические соединения
RU94012931A (ru) Гидразиды 1н-индол-3-уксусной кислоты как ингибиторы spla2
RU94012930A (ru) Новые 1-н-индол-3-ацетамиды как ингибиторы spla2 и фармацевтическая композиция на их основе
ES2160897T3 (es) Pirazoles como inhibidores de la secretora fosfolipasa a2 humana no pancreatica.
YU20194A (sh) 1H-INDOL-3-ACETAMIDI KAO INHIBITORI s PLA2
DK0620214T3 (da) 1H-indol-3-eddikesyrehydrazid som sPLA2-inhibitorer
BR9713261A (pt) Tricìclicos substituìdos
AR009358A1 (es) Compuesto espirociclico inhibidor de la metaloproteasa
EA199900304A2 (ru) Замещенные трициклические соединения
ES2195182T3 (es) Fenil glioxamidas como inhibidores de spla2.
ES2174034T3 (es) Naftilglioxamidas como inhibidores de spla2
ES2181052T3 (es) Fenilacetamidas como inhibidores de la spla2.
EP1100492A4 (en) SPLA 2 INHIBITORS? INDOLE TYPE
ATE247119T1 (de) Substituierte pyrroloindole
DE60032774D1 (de) Spla2 inhibitoren
BR9612000A (pt) Naftil glioxamidas como inibidores de spla; '
ECSP992929A (es) Compuestos triciclicos sustituidos (caso x-12143)
ECSP992928A (es) Compuestos triciclicos sustituidos (caso x-12144)

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 779271

Country of ref document: ES